Barbara Bardoni Genetics

Course and current status

PRESENT POSITION: (From January 2008)

DR1 INSERM - Group leader at the IPMC- CNRS UMR6097, Valbonne (France).

EMPLOYMENT AND RESEARCH EXPERIENCE 

1987-90: Research fellow Faculty of Medicine, University of Pavia (Italy) in Pof. Giovanna Camerino’s laboratory.  

1991-2001: Assistant Professor, Faculty of Medicine, University of Pavia

 

2002-2004: Researcher (CR1) INSERM at IGBMC – Illkirch (France).

2005-2007: Group leader ATIP at CNRS UMR6543. Faculty of Medicine, Nice, FRANCE.

2007: Nomination Directeur de Recherche (Equivalent Professor)

2008 to present: Group leader at IPMC, CNRS UMR6097, Valbonne (France). Team: “Physiopathology of Mental Retardation”

Honours and Awards

Award and Fellowship

1988: Price “Rino Minoprio” for the Excellence in Human Genetics; 1988-90: Fellowship ”AnnaVilla Rusconi”; 1994: EMBO Short-Term Fellowship; 1996-98: Italian Telethon Fellowship; 1998-99: FRM Fellowship; 2004: ATIP; 2007: ATIP PLUS; 2014: 6ème Prix du Conseil General06.

 GRANTS:

PI: NIMH/NICHD/FRAXA cofunding (2001-04), ATIP (2004-07); FRM New laboratory (2005) GIS Maladies Rares (2005-08); ANR-Neurosci (2006-09; 2013-17); ATIP Plus (2007-09); BQR (2009); MRT Thèse Flechée (2009-12); FRM TEAM (20010-13; 2014-17); FRAXA Foundation (2000; 2006); Jerôme Lejeune Foundation (2004/10; 2014/16; 2018-20); IngFRM (2014); FRC (2019-20)AFM (2014-16); Prematuration UCA-SATT (2019)

 Co-Investigator: EEC (1995-96); HFSP (2002-2005); ULP (2002); ANR Blanc (2006-09); Marie Curie-RI (2009-12); ANR E-RARE (2010-13); LabEX “Signalife (2012-19); Fondation Maladies Rares (2014-16); ANR-AAP (2016-120); FRAXA Foundation (2016-19).

 Exchanging grants: France-Canada cooperation grant. PI: E.W. Khandjian (2004); « Ambassade de Canada » Québec, avec Prof. E. Khandjian (2008): « G. Galilei » (Italy) avec Dr. M.V. Catania (2007-08); FAST (Australia) (2009-10) Prof. J. Gecz ; Ulysse (Ireland) (2019) Dr. D. Tropea ; MAUPERTUIS (Finland) (2019) Dr. M. Castren.

EDITORIAL ACTIVITY :

Board member: PLOS ONE; Frontiers in Molecular Neuroscience; Frontiers in Synaptic Neuroscience; Frontiers in Molecular Bioscience section RNA Proteins Network.

2013 Guest Editor : Neuroscience and Biobehavioural Reviews : « Common Mechanisms in Intellectual Disabilities: A Challenge for Translational Outlooks »

 

MISCELLANEOUS:

Referee «ad hoc» for the following journals: Cell Rep ; E.J. Hum. Genet.; E.J. Neurosci.; HMG; J. Mol. Biol., JMG; J. Neurosci.; Mol. Psychiatry ; Nature; MCB; Neuroscience; Neurobiol. Dis.; NAR;PLOS Genet ;  PLOS One; PNAS; Science, Trends Genet.

Referee «ad hoc» for AFM (Association Française contre les Myopathies); ANR (Agence Nationale de la Recherche); Horizon Program (Netherland Genomics Initiative); ); ISF (Israel Science Foundation); Italian Teletho ; Italian Ministry of Health;.NWO Division for Earth and Life Sciences (The Netherlands); Eurpean Science Foundation.

2008 Member of the evaluation committee for Life Science Master of University of Nice

2010 Member of a visiting committee of AERES 

Member of an evaluation committee for a researcher position (MCU) at the University of Nice

Chair of the Jacques Monod Conference «Mental Retardation: from genes to synapses, functions and dysfunctions ». Roscoff (France), October 7-11, 2010

2012-17 Member of Laboratory Council of IPMC

2013 Chair of «  G-Quadruplex Day », Nice, March 22

Member of the Scientific Board of the Meeting « XVI Workshop on Fragile X and other early-onset neurodevelopmental disorders », Adelaide (Australia), 17-20 September.

Co-Organizers of «RNA metabolism: Cancer, development and disease » Nice, December 4-6;

2014-2016 Member of the Selection committee of Signalife PhD Program

2015- to present: Member of Scientific Committee of « Fondation J. Lejeune »

2016-19 Member of Scientific Committee of LabEx « Signalife » 

2016 Member of Evaluation Committee ATIP –AVIESAN

2016-21 Member of Evaluation Committee CSS2-INSERM

2018 Organiser of The multiple facets of RNA in development and in disease”, Nice February 7-8.

Member of Scientific Committee of SIFRARN Meeting, Nancy November 22.

Member HCERES visit Imagine Institute – Paris.

2019: Member of Scientific Board of the Meeting « XIX Workshop on Fragile X and other early-onset neurodevelopmental disorders », Sorrento (Italy), September 18-21.

Scientific summary

Research:

Image d’exemple